APA (7th ed.) Citation

Pan, X., Mao, T., Mai, Y., Liang, C., Huang, W., Rao, Y., . . . Huang, S. (2022). Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy. MDPI AG.

Chicago Style (17th ed.) Citation

Pan, Xin, Teng-yu Mao, Yan-wen Mai, Cheng-cheng Liang, Wei-hao Huang, Yong Rao, Zhi-shu Huang, and Shi-liang Huang. Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy. MDPI AG, 2022.

MLA (9th ed.) Citation

Pan, Xin, et al. Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy. MDPI AG, 2022.